Pharmaceutical cognitive doping in students: A chimeric way to get-a-head?

Area of Science:

• Neuroscience
• Pharmacology
• Educational Psychology

Background:

• Academic pressure and competition drive students towards cognitive enhancement.
• Pharmaceutical cognitive doping involves using prescription and illicit substances, as well as over-the-counter products.

Purpose of the Study:

• To describe current practices of pharmaceutical cognitive doping among students.
• To evaluate the benefit/risk ratio of cognitive doping.
• To discuss the broader implications of this behavior.

Main Methods:

• Literature review of studies on pharmaceutical cognitive doping prevalence.
• Analysis of cited substances and student motivations.
• Discussion of ethical and regulatory issues.

Main Results:

• Prevalence rates vary widely (1.3%–33%) depending on study definitions and location.
• Commonly diverted drugs include psychostimulants (methylphenidate), nootropics (modafinil), and others like corticosteroids and beta-blockers.
• The perceived cognitive benefits are often overstated, with modest and debated actual effects.

Conclusions:

• Cognitive doping poses risks to student health, academic fairness, and success.
• Regulation and prevention strategies, including enhanced university health services, are crucial.
• Addressing the underlying pressures contributing to doping behavior is essential.